Physician profile
William Sovic
NPI 1225590813
$59,870.50
in general payments reported to CMS, 2019-2025
12 companies · $57K in 2025
The $57K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $231 · 2023: $2,098 · 2024: $982 · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $45K · Travel and Lodging: $7,967 · Food and Beverage: $6,276 · Education: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $45,000.00 |
| Travel and Lodging | $7,966.93 |
| Food and Beverage | $6,275.71 |
| Education | $396.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $29,454.48 | 2023-2025 | Tacticath, Assurity, Mitraclip |
| Medtronic, INC. | $22,495.52 | 2023-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Advisa Dr Mri Surescan |
| Boston Scientific Corporation | $4,569.89 | 2023-2025 | Farapulse, Versacross Rf Wire, Ingevity Mri |
| Biotronik INC. | $2,197.68 | 2025 | |
| Edwards Lifesciences Corporation | $317.59 | 2022-2023 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $309.07 | 2024-2025 | Lm Undivided, (5044) Mcot |
| Shockwave Medical, INC | $208.23 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $194.34 | 2023-2024 | Repatha |
| Abiomed | $51.55 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2022 | |
| Pfizer INC. | $25.43 | 2022 | |
| Kestra Medical Technology Services, INC. | $16.96 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.